No Data
Tosei, Aeon Delaire, Etc (additional) Rating
Upgraded - Bullish Ticker Symbol Company Name Brokerage Firm Previous Change After --------------------------------------------------- <7735> Screen Mizuho "Hold" "Buy" Downgraded - Bearish Ticker Symbol Company Name Brokerage Firm Previous Change After --------------------------------------------------- <6586> Makita GS "Buy" "Hold" <6857> Advante Mizuho "Buy"
Drugs Not Selected for Medicare Price Negotiation Nearly Doubled - Report
The Nikkei average fell by 375 yen and continued to decline, although it expanded its drop at one point, it began to recover towards the end of the Trade = September 9, afternoon session.
On the 9th, in the afternoon session, the Nikkei average fell by 375.97 yen to 39,605.09 yen, while the TOPIX (Tokyo Stock Price Index) dropped 34.08 points to 2,735.92 points, both continuing to decline. The weak conditions from the morning session persisted, and trading began with selling dominating the market. Continued weakened performance in Extended hours trading for US stock index Futures has also influenced the Nikkei average, which reached 39,385.05 yen, down 596.01 yen, at 1:05 PM.
Nikkei Average Contribution Ranking (Before Closing) ~ The Nikkei Average continues to decline, with Tokyo Electron pushing it down by about 41 yen with just one stock.
As of the closing on nine days ago, the number of rising and falling stocks in the Nikkei average was 44 rising, 181 falling, and 0 unchanged. The Nikkei average continued to decline, ending the morning session at 39,678.93 yen, down 302.13 yen (−0.76%) compared to the previous day, with an estimated Volume of 0.9 billion shares. On the 8th, the USA market showed mixed results. The Dow Inc rose by 106.84 dollars to 42,635.20 dollars, while the Nasdaq ended trading down 10.80 points at 19,478.88. Employment-related Indicators showed mixed strength.
FDA Accepts Astellas Pharma's Revised SNDA For IZERVAY In Geographic Atrophy Treatment
Astellas Pharma's Resubmission for IZERVAY Accepted by FDA
No Data
